olokizumab
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The anti-IL-6 tocilizumab is a recognized treatment in rheumatoid arthritis and in systemic juvenile idiopathic arthritis. Almost…
Background Olokizumab (OKZ) is an anti-interleukin-6 (IL-6) monoclonal antibody in development for the treatment of rheumatoid…
Background Rheumatoid arthritis (RA) has a high patient (pt) burden with significant impact on health-related quality of life…
Objectives Tocilizumab (TCZ) is a humanized monoclonal antibody against the α-chain of the IL6 receptor. In clinical trials TCZ…